Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Highly Accessed Editorial

Bisphosphonates for osteoarthritis

David A Walsh* and Victoria Chapman

Author affiliations

Arthritis Research UK Pain Centre, Academic Rheumatology, University of Nottingham Clinical Sciences Building, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK

For all author emails, please log on.

Citation and License

Arthritis Research & Therapy 2011, 13:128  doi:10.1186/ar3448

Published: 30 September 2011

Abstract

Synovitis and subchondral bone turnover are associated with pain in osteoarthritis. Bisphosphonates provide tools for investigating these pathogenic mechanisms and also may have therapeutic potential. Translating preclinical findings into new treatments for human osteoarthritis requires a critical appraisal and refinement of animal models, identification of those pathogenic mechanisms that are amenable to intervention, and pharmacological targeting of those mechanisms in the right people at the right time.